article = {JDMC-2020-2-101}
title = {Obesity and Metabolic Associated Fatty Liver Disease (MAFLD) as Risk Factors for COVID-19 Severity}
journal = {Journal of Diabetes Metabolism and its Complications}
year = {2020}
issn = {2674-4163}
doi = {http://dx.doi.org/10.31487/j.JDMC.2020.02.01}
url = {https://www.sciencerepository.org/obesity-and-metabolic-associated-fatty-liver-disease-mafld-as-risk_JDMC-2020-2-101 
author = {Gamal  Shiha,Reham  Soliman,}
keywords = {MAFLD, obesity, COVID-19}
abstract ={In December 2019 Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China and rapidly spread
to other areas and has been declared a pandemic in 2020. Until now there are about half million deaths.
Of note the highest fatality rate was found for cardiovascular disease, diabetes mellitus followed by
chronic respiratory diseases, hypertension and cancer. Remarkably early data have reported higher BMI
is associated with a higher risk of developing severe symptoms and complications of COVID-19 disease.
Patients with metabolic associated fatty liver disease (MAFLD) are often obese and have additional
metabolic risk factors which may increase risk of respiratory diseases. Identification of risk factors of
COVID-19 severity is crucial to provide additional medical care; in this review we shed light on the
association between MAFLD and COVID-19 severity.}